PROSTATE HEALTH INDEX (phi) BLOOD TEST GIVES YOU MORE CONFIDENCE BEFORE BIOPSY, REDUCING UNNECESSARY BIOPSIES BY 30% BREA, CALIF. — (May 6, 2016) — Beckman Coulter Diagnostics, a leader in prostate cancer testing, will demonstrate its dedication to advancing healthcare for patients and physicians at the 2016 American Urological Association (AUA) Annual Meeting in... Read more
ImageXpress and MetaXpress High-Content Toolset Enables Breakthrough Three-Dimensional Assay Development and Screening Workflow for Cellular Research Sunnyvale, Calif. – April 19, 2016 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of its ImageXpress® Micro 4 High-Content Imaging System and revolutionary 3D image analysis capability in the latest version... Read more
NYON, SWITZERLAND – (January 21, 2016) – Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems. This new assay is the next generation of the Access HYPERsensitive hTSH and Access Fast hTSH... Read more
Beckman Coulter Inc – Beckman Coulter, Inc. JavaScript is required for this site. Please enable JavasScript for your browser. Change Password * Indicates required fields Change Email Address * Indicates required fields Confirm Country Selection Forgot Password * Indicates required fields Forgot your password? Please provide the email address and your last name associated... Read more
Sunnyvale, California, October 12, 2015. Molecular Devices LLC, a leader in protein and cell biology technologies, is pleased to announce it has been awarded the New Product Innovation Award for the ImageXpress® Micro Confocal High Content Imaging system, launched at the recent Miptec conference in Basel, Switzerland. The award is in recognition for the AgileOptix™... Read more
Access Anti-Müllerian Hormone (AMH) Assay Voted Best New Clinical Product of 2014 BREA, CALIF. – (August 31, 2015) – Beckman Coulter Diagnostics’ automated Access Anti-Müllerian Hormone (AMH) assay* was recently selected as the Best New Clinical Laboratory Product of 2014 for the 2015 Scientists’ Choice Award by members of SelectScience®. The award was presented... Read more
ImageXpress Micro Confocal High-Content Imaging System expands the boundaries of researchConfocal technology at the speed of widefield imaging Sunnyvale, California, September 1, 2015. Molecular Devices today announced the launch of the new ImageXpress® Micro Confocal High-Content Imaging System. This transformative system fits a broad range of automated cell-based imaging applications, especially emerging assays that use... Read more
Beckman Coulter Diagnostics and COPAN, a company committed to innovation in the field of pre-analytics, recently announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories. Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab... Read more
Standardized Processes and Improved Operational Efficiency Move Healthcare Forward BREA, CALIF. — (July 24, 2015) — Beckman Coulter Diagnostics will be showcasing its comprehensive portfolio of high-productivity analytical and workflow systems at the 2015 American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga., July 28-30, 2015. Clinical Lab... Read more
Sunnyvale, California, July 15, 2015. Molecular Devices today announced the launch of six EarlyTox™ cell viability assay kits, a new family of fluorescence-based reagents optimized for microplate readers to assess cell viability, cell proliferation, and apoptosis events in mammalian cells. Cell viability assays are critical to a broad spectrum of research areas ranging from understanding... Read more